BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 26521141)

  • 1. Roflumilast partially reverses smoke-induced mucociliary dysfunction.
    Schmid A; Baumlin N; Ivonnet P; Dennis JS; Campos M; Krick S; Salathe M
    Respir Res; 2015 Oct; 16():135. PubMed ID: 26521141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystic fibrosis transmembrane conductance regulator activation by roflumilast contributes to therapeutic benefit in chronic bronchitis.
    Lambert JA; Raju SV; Tang LP; McNicholas CM; Li Y; Courville CA; Farris RF; Coricor GE; Smoot LH; Mazur MM; Dransfield MT; Bolger GB; Rowe SM
    Am J Respir Cell Mol Biol; 2014 Mar; 50(3):549-58. PubMed ID: 24106801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roflumilast combined with adenosine increases mucosal hydration in human airway epithelial cultures after cigarette smoke exposure.
    Tyrrell J; Qian X; Freire J; Tarran R
    Am J Physiol Lung Cell Mol Physiol; 2015 May; 308(10):L1068-77. PubMed ID: 25795727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roflumilast N-oxide inhibits bronchial epithelial to mesenchymal transition induced by cigarette smoke in smokers with COPD.
    Milara J; Peiró T; Serrano A; Guijarro R; Zaragozá C; Tenor H; Cortijo J
    Pulm Pharmacol Ther; 2014 Aug; 28(2):138-48. PubMed ID: 24525294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roflumilast reverses CFTR-mediated ion transport dysfunction in cigarette smoke-exposed mice.
    Raju SV; Rasmussen L; Sloane PA; Tang LP; Libby EF; Rowe SM
    Respir Res; 2017 Sep; 18(1):173. PubMed ID: 28923049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roflumilast N-oxide, a PDE4 inhibitor, improves cilia motility and ciliated human bronchial epithelial cells compromised by cigarette smoke in vitro.
    Milara J; Armengot M; Bañuls P; Tenor H; Beume R; Artigues E; Cortijo J
    Br J Pharmacol; 2012 Aug; 166(8):2243-62. PubMed ID: 22385203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Cystic Fibrosis Transmembrane Conductance Regulator Potentiator Ivacaftor Augments Mucociliary Clearance Abrogating Cystic Fibrosis Transmembrane Conductance Regulator Inhibition by Cigarette Smoke.
    Raju SV; Lin VY; Liu L; McNicholas CM; Karki S; Sloane PA; Tang L; Jackson PL; Wang W; Wilson L; Macon KJ; Mazur M; Kappes JC; DeLucas LJ; Barnes S; Kirk K; Tearney GJ; Rowe SM
    Am J Respir Cell Mol Biol; 2017 Jan; 56(1):99-108. PubMed ID: 27585394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic activation of cystic fibrosis transmembrane conductance regulator by type 3 and type 4D phosphodiesterase inhibitors.
    Liu S; Veilleux A; Zhang L; Young A; Kwok E; Laliberté F; Chung C; Tota MR; Dubé D; Friesen RW; Huang Z
    J Pharmacol Exp Ther; 2005 Aug; 314(2):846-54. PubMed ID: 15901792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-β1 and cigarette smoke inhibit the ability of β2-agonists to enhance epithelial permeability.
    Unwalla HJ; Ivonnet P; Dennis JS; Conner GE; Salathe M
    Am J Respir Cell Mol Biol; 2015 Jan; 52(1):65-74. PubMed ID: 24978189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sinupret activates CFTR and TMEM16A-dependent transepithelial chloride transport and improves indicators of mucociliary clearance.
    Zhang S; Skinner D; Hicks SB; Bevensee MO; Sorscher EJ; Lazrak A; Matalon S; McNicholas CM; Woodworth BA
    PLoS One; 2014; 9(8):e104090. PubMed ID: 25117505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simvastatin Increases the Ability of Roflumilast N-oxide to Inhibit Cigarette Smoke-Induced Epithelial to Mesenchymal Transition in Well-differentiated Human Bronchial Epithelial Cells in vitro.
    Milara J; Peiró T; Serrano A; Artigues E; Aparicio J; Tenor H; Sanz C; Cortijo J
    COPD; 2015 Jun; 12(3):320-31. PubMed ID: 25207459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cigarette and ENDS preparations differentially regulate ion channels and mucociliary clearance in primary normal human bronchial 3D cultures.
    Rayner RE; Makena P; Prasad GL; Cormet-Boyaka E
    Am J Physiol Lung Cell Mol Physiol; 2019 Aug; 317(2):L295-L302. PubMed ID: 31166129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphodiesterase-4 inhibition augments human lung fibroblast vascular endothelial growth factor production induced by prostaglandin E2.
    Ikari J; Michalski JM; Iwasawa S; Gunji Y; Nogel S; Park JH; Nelson AJ; Farid M; Wang X; Schulte N; Basma H; Toews ML; Feghali-Bostwick C; Tenor H; Liu X; Rennard SI
    Am J Respir Cell Mol Biol; 2013 Oct; 49(4):571-81. PubMed ID: 23656623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol ameliorates abnormalities of fluid and electrolyte secretion in a hypoxia-Induced model of acquired CFTR deficiency.
    Woodworth BA
    Laryngoscope; 2015 Oct; 125 Suppl 7(0 7):S1-S13. PubMed ID: 25946147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cigarette smoke activates CFTR through ROS-stimulated cAMP signaling in human bronchial epithelial cells.
    Wong FH; AbuArish A; Matthes E; Turner MJ; Greene LE; Cloutier A; Robert R; Thomas DY; Cosa G; Cantin AM; Hanrahan JW
    Am J Physiol Cell Physiol; 2018 Jan; 314(1):C118-C134. PubMed ID: 28978522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cyclic AMP-elevating agents on airway ciliary beat frequency in central and lateral airways in rat precision-cut lung slices.
    Wohlsen A; Hirrle A; Tenor H; Marx D; Beume R
    Eur J Pharmacol; 2010 Jun; 635(1-3):177-83. PubMed ID: 20303939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cystic fibrosis transmembrane conductance regulator activation by the solvent ethanol: implications for topical drug delivery.
    Cho DY; Skinner D; Zhang S; Fortenberry J; Sorscher EJ; Dean NR; Woodworth BA
    Int Forum Allergy Rhinol; 2016 Feb; 6(2):178-84. PubMed ID: 26869199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cigarette smoke exposure reveals a novel role for the MEK/ERK1/2 MAPK pathway in regulation of CFTR.
    Xu X; Balsiger R; Tyrrell J; Boyaka PN; Tarran R; Cormet-Boyaka E
    Biochim Biophys Acta; 2015 Jun; 1850(6):1224-32. PubMed ID: 25697727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucociliary Clearance in Former Tobacco Smokers with Both Chronic Obstructive Pulmonary Disease and Chronic Bronchitis and the Effect of Roflumilast.
    Laube BL; Carson KA; Sharpless G; Paulin LM; Hansel NN
    J Aerosol Med Pulm Drug Deliv; 2019 Aug; 32(4):189-199. PubMed ID: 30964381
    [No Abstract]   [Full Text] [Related]  

  • 20. Cystic fibrosis transmembrane conductance regulator modulation by the tobacco smoke toxin acrolein.
    Alexander NS; Blount A; Zhang S; Skinner D; Hicks SB; Chestnut M; Kebbel FA; Sorscher EJ; Woodworth BA
    Laryngoscope; 2012 Jun; 122(6):1193-7. PubMed ID: 22522920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.